Comparison of Patient-controlled Analgesia Regimenfor Postoperative Pain in Patients Undergoing Total Knee Arthroplasty
1 other identifier
interventional
98
1 country
1
Brief Summary
Patients who undergoing total knee arthroplasty under spinal analgesia will be recruited and randomly assigned to the following two groups according to the regimen of PCA: (A) opioid group who receive only fentanyl citrate 1200mcg for continuous infusion drug, (B) non-opioid group who receive ketorolac tromethamine 150mg with nefopam hydrochloride 100mg for continuous infusion drug. All the patients will receive additional fentanyl citrate as bolus injection drug if they need more analgesics postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 7, 2023
CompletedFirst Submitted
Initial submission to the registry
February 8, 2023
CompletedFirst Posted
Study publicly available on registry
May 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2024
CompletedJuly 15, 2024
July 1, 2024
1.4 years
February 8, 2023
July 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
postoperative pain score
evaluated by visual analogue scale
24 hours after the surgery
Study Arms (2)
opioid group
EXPERIMENTALIV-PCA consisted of fentanyl
non-opioid group
ACTIVE COMPARATORIV-PCA consisted of ketorolac and nefopam
Interventions
opioid group receives only fentanyl citrate 1200mcg for continuous infusion drug
non-opioid group receives ketorolac tromethamine 150mg with nefopam hydrochloride 100mg for continuous infusion drug
Eligibility Criteria
You may qualify if:
- ASA physical status I-II
- undergoing elective total knee arthroplasty under spinal anesthesia
You may not qualify if:
- history of stomack ulceration
- increased ICP
- bronchial asthma
- allergy on aspirin, NSAIDs, Nefopam
- drug user of antiplatelet or anticoagulant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ChungAng University Gwangmyeong Hospital
Gyeonggi-do, Gwangmyeon-si, 14353, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Se-Hee Min
ChungAng University Gwangmyeon Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
February 8, 2023
First Posted
May 17, 2023
Study Start
February 7, 2023
Primary Completion
July 12, 2024
Study Completion
July 12, 2024
Last Updated
July 15, 2024
Record last verified: 2024-07